Modifies provisions relating to gender transition procedures

HB 1038 prohibits health care providers from performing gender transition surgeries on individuals under 18 and restricts prescribing cross-sex hormones or puberty-blocking drugs for gender transition to those under 18, with exceptions for certain medical conditions (like disorders of sex development) and a temporary allowance for existing treatments until March 2026. Violations could result in license revocation for providers. The bill also creates a new legal pathway for minors to sue providers for harm related to these treatments, including a rebuttable presumption of harm if infertility occurs, with specific rules for damages and confidentiality. It directly affects minors seeking gender transition care, their health care providers, and the legal landscape around such medical decisions.